A detailed history of Arizona State Retirement System transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Arizona State Retirement System holds 26,462 shares of VIR stock, worth $199,258. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,462
Previous 25,879 2.25%
Holding current value
$199,258
Previous $262,000 10.31%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$7.63 - $12.66 $4,448 - $7,380
583 Added 2.25%
26,462 $235,000
Q1 2024

May 07, 2024

SELL
$8.6 - $11.9 $3,371 - $4,664
-392 Reduced 1.49%
25,879 $262,000
Q4 2023

Jan 24, 2024

BUY
$7.76 - $10.29 $11,453 - $15,188
1,476 Added 5.95%
26,271 $264,000
Q3 2023

Nov 06, 2023

BUY
$9.14 - $24.62 $3,135 - $8,444
343 Added 1.4%
24,795 $232,000
Q2 2023

Aug 01, 2023

BUY
$23.2 - $27.29 $75,121 - $88,365
3,238 Added 15.26%
24,452 $599,000
Q1 2023

Apr 27, 2023

BUY
$22.26 - $30.85 $14,001 - $19,404
629 Added 3.06%
21,214 $493,000
Q4 2022

Feb 07, 2023

BUY
$19.96 - $28.22 $15,968 - $22,576
800 Added 4.04%
20,585 $521,000
Q3 2022

Nov 07, 2022

BUY
$18.26 - $31.1 $4,291 - $7,308
235 Added 1.2%
19,785 $381,000
Q2 2022

Jul 28, 2022

BUY
$19.08 - $26.7 $35,507 - $49,688
1,861 Added 10.52%
19,550 $498,000
Q1 2022

May 04, 2022

BUY
$21.19 - $40.01 $2,373 - $4,481
112 Added 0.64%
17,689 $455,000
Q4 2021

Feb 04, 2022

SELL
$30.97 - $54.03 $4,149 - $7,240
-134 Reduced 0.76%
17,577 $736,000
Q3 2021

Nov 12, 2021

BUY
$34.9 - $54.54 $11,726 - $18,325
336 Added 1.93%
17,711 $771,000
Q2 2021

Aug 02, 2021

BUY
$38.75 - $51.0 $673,281 - $886,125
17,375 New
17,375 $821,000

Others Institutions Holding VIR

About Vir Biotechnology, Inc.


  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $999M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.